The FDA is warning health providers and patients to avoid use of smart devices like watches and rings that purport to measure glucose levels without piercing the skin, the agency announced Feb. 21.

Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. Lingo contains a biosensor and mobile app that ...

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...

A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...

This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...

The idea of tracking blood sugar without needles has challenged health tech for years. For people with diabetes, constant monitoring is critical, yet the tools remain uncomfortable and invasive.

NEWARK, DELAWARE / ACCESS Newswire / February 18, 2026 / The Glucose Monitoring Device Market is poised for robust expansion, projected to grow from USD 17.9 billion in 2026 to USD 49.3 billion by ...

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The global blood glucose monitoring devices market size is estimated to grow by USD 8.70 billion from 2024-2028, according to Technavio. The market is estimated ...